Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center

Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology
Ayhan PektaşAytemiz Gurgey

Abstract

This study aims to document and analyze the central venous catheter (CVC)-related complications in children with hematological diseases who were treated within a single institution. A retrospective investigation was conducted in 106 pediatric patients in whom 203 CVCs were inserted. A total of 175 catheter-related complications occurred in 5 years. The rates of clinical catheter infections, local catheter infections, venous thromboembolism, bleeding, and mechanical complications were 2.6, 1.1, 0.2, 0.2, and 0.2 per 1000 catheter days. Methicillin-resistant Staphylococcus epidermidis was the predominant infectious organism in blood and catheter cultures. The children with leukemia had a significantly higher frequency of clinical catheter infections (p=0.046). The children who underwent bone marrow transplantation had a significantly lower frequency of clinical catheter infections (p=0.043) and higher frequency of local catheter infections (p=0.003). The children with implanted catheters had a significantly lower frequency of clinical catheter infections (p=0.048). The children with thrombocytopenia had significantly fewer local catheter infections and significantly more clinical catheter infections and catheter-related bleeding ...Continue Reading

Citations

Sep 15, 2017·Cardiovascular and Interventional Radiology·Annika R KeulersAndreas H Mahnken
Mar 12, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Ewelina GowinDanuta Januszkiewicz-Lewandowska
Nov 24, 2019·Pediatrics·Ana Cristina Carvalho da CostaPaula Elaine Diniz Dos Reis

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

SPSS

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.